| Literature DB >> 25871822 |
Bertrand Grenier1,2, Heidi E Schwartz-Zimmermann3, Sylvia Caha4, Wulf Dieter Moll5, Gerd Schatzmayr6, Todd J Applegate7.
Abstract
In chickens, the effect of mycotoxins, especially fumonisins (FB), in the gastrointestinal tract (GIT) is not well documented. Thus, this study in broiler chicks determined the effects of consuming diets prepared with Fusarium verticillioides culture material containing FB on intestinal gene expression and on the sphinganine (Sa)/sphingosine (So) ratio (Sa/So; a biomarker of FB effect due to disruption of sphingolipid metabolism). Male broilers were assigned to 6 diets (6 cages/diet; 6 birds/cage) from hatch to 20 days containing 0.4, 5.6, 11.3, 17.5, 47.8, or 104.8 mg FB/kg diet. Exposure to FB altered the Sa/So ratio in all tissues analyzed, albeit to varying extents. Linear dose-responses were observed in the kidney, jejunum and cecum. The liver and the ileum were very sensitive and data fit a cubic and quadratic polynomial model, respectively. Gene expression in the small intestine revealed low but significant upregulations of cytokines involved in the pro-inflammatory, Th1/Th17 and Treg responses, especially at 10 days of age. Interestingly, the cecal tonsils exhibited a biphasic response. Unlike the sphingolipid analysis, the effects seen on gene expression were not dose dependent, even showing more effects when birds were exposed to 11.3 mg FB/kg. In conclusion, this is the first report on the disruption of the sphingolipid metabolism by FB in the GIT of poultry. Further studies are needed to reach conclusions on the biological meaning of the immunomodulation observed in the GIT, but the susceptibility of chickens to intestinal pathogens when exposed to FB, at doses lower than those that would cause overt clinical symptoms, should be addressed.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25871822 PMCID: PMC4417966 DOI: 10.3390/toxins7041253
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Overview of the Sa/So ratios in both intestinal and non-intestinal tissues.
| Sa/So ratios | Liver | Kidney | Jejunum | Ileum | Cecum | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| FB in Diet (mg/kg) | d10 | d20 | d10 | d20 | d10 | d20 | d10 | d20 | d10 | d20 |
| 0.23 ± 0.04 | 0.17 ± 0.02 | 0.14 ± 0.01 | 0.16 ± 0.02 | 0.22 ± 0.01 | 0.25 ± 0.02 | 0.31 ± 0.06 | 0.27 ± 0.05 | 0.14 ± 0.02 | 0.19 ± 0.04 | |
| 0.33 ± 0.03 ** | 0.19 ± 0.02 | 0.14 ± 0.02 | 0.14 ± 0.02 | 0.29 ± 0.03 | 0.28 ± 0.02 * | 0.51 ± 0.11 | 0.52 ± 0.21 | 0.23 ± 0.01 | 0.13 ± 0.01 * | |
| 0.40 ± 0.02 *** | 0.31 ± 0.02 ** | 0.20 ± 0.03 | 0.21 ± 0.03 | 0.67 ± 0.08 * | 0.60 ± 0.03 *** | 2.06 ± 0.20 ** | 1.93 ± 0.47 * | 0.42 ± 0.03 ** | 0.35 ± 0.03 ** | |
| 1.82 ± 0.15 ** | 1.66 ± 0.17 ** | 0.66 ± 0.07 ** | 0.55 ± 0.09 * | 0.93 ± 0.19 | 1.12 ± 0.49 | 3.61 ± 0.30 ** | 2.37 ± 0.80 | 0.75 ± 0.18 | 0.38 ± 0.02 ** | |
| 2.18 ± 0.12 *** | 2.22 ± 0.21 ** | 1.39 ± 0.29 * | 1.72 ± 0.48 | 1.89 ± 0.34 * | 0.95 ± 0.14 * | 4.08 ± 1.00 * | 2.88 ± 0.48 * | 0.62 ± 0.08 * | 0.44 ± 0.04 *** | |
| <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.011 | <0.001 | <0.001 | <0.001 | <0.001 | |
Values are mean ± SEM for six animals. * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001 compared to control group.
Figure 1Dose-response effect of FB on the Sa/So ratio in intestinal and non-intestinal tissues. A model of regression was used and the coefficients of determination are indicated. Data in the kidney and jejunum fit linear regression at both sampling times. In the liver, cubic polynomial regressions were found. Data in the ileum follow a quadratic polynomial model. Individual values are displayed, six animals per experimental diet.
Gene expression in the small intestine of chickens fed increasing concentrations of FB—Relative fold to the control group.
| FB in diet (mg/kg) | Pro-inflammatory cytokines | Treg signature | Th1 & Th17 signature | ||||||
|---|---|---|---|---|---|---|---|---|---|
| IL-1β | IL-8 | IL-6 | IL-10 | TGFβ1 | SOCS1 | IL-17 | IL-21 | IFN-γ | |
| 5.6 | 2.11 ± 0.35 ** | 1.02 ± 0.14 | 1.15 ± 0.25 | 1.40 ± 0.30 | 1.12 ± 0.14 | 1.20 ± 0.11 | 1.20 ± 0.31 | 1.53 ± 0.30 | 1.29 ± 0.16 |
| 11.3 | 2.39 ± 0.26 *** | 1.74 ± 0.40 | 0.95 ± 0.13 | 3.76 ± 0.65 ** | 0.94 ± 0.07 | 1.29 ± 0.13 | 2.32 ± 0.22 * | 1.69 ± 0.20 | 1.61 ± 0.15 |
| 17.5 | 1.96 ± 0.14 ** | 1.29 ± 0.23 | 1.52 ± 0.14 | 3.45 ± 0.82 * | 1.12 ± 0.11 | 1.32 ± 0.19 | 1.58 ± 0.50 | 2.40 ± 0.63 * | 2.17 ± 0.48 ** |
| 47.8 | 2.08 ± 0.20 ** | 1.63 ± 0.18 | 1.82 ± 0.36 | 2.07 ± 0.59 | 0.98 ± 0.10 | 1.39 ± 0.31 | 1.09 ± 0.17 | 1.78 ± 0.19 | 1.61 ± 0.24 |
| 104.8 | 1.80 ± 0.16 * | 2.54 ± 0.36 *** | 2.37 ± 0.96 | 2.40 ± 0.61 | 1.06 ± 0.12 | 1.31 ± 0.11 | 0.82 ± 0.09 | 2.19 ± 0.33 * | 1.60 ± 0.25 |
| Probability of the diet effect | 0.004 | 0.004 | 0.199 | 0.014 | 0.765 | 0.677 | 0.021 | 0.101 | 0.116 |
| 5.6 | 1.00 ± 0.30 | 0.94 ± 0.39 | 0.88 ± 0.10 | 0.50 ± 0.14 | 1.09 ± 0.13 | 0.90 ± 0.18 | 1.56 ± 0.77 | 1.10 ± 0.29 | 0.65 ± 0.13 |
| 11.3 | 1.66 ± 0.47 | 2.20 ± 0.81 | 1.85 ± 0.42 | 0.86 ± 0.09 | 1.54 ± 0.12 * | 2.03 ± 0.50 * | 4.47 ± 1.36 * | 1.52 ± 0.20 | 1.51 ± 0.09 |
| 17.5 | 0.69 ± 0.09 | 1.17 ± 0.32 | 0.70 ± 0.09 | 0.82 ± 0.27 | 1.83 ± 0.20 ** | 1.18 ± 0.28 | 0.59 ± 0.11 | 1.27 ± 0.33 | 1.23 ± 0.27 |
| 47.8 | 0.55 ± 0.05 * | 1.47 ± 0.71 | 2.24 ± 1.07 | 0.84 ± 0.43 | 1.17 ± 0.09 | 0.89 ± 0.14 | 0.77 ± 0.23 | 1.49 ± 0.73 | 1.11 ± 0.48 |
| 104.8 | 1.13 ± 0.15 | 2.14 ± 0.61 | 1.13 ± 0.24 | 0.57 ± 0.08 | 1.73 ± 0.18 ** | 1.60 ± 0.22 | 3.41 ± 1.57 | 1.26 ± 0.25 | 1.04 ± 0.09 |
| Probability of the diet effect | 0.069 | 0.470 | 0.258 | 0.792 | 0.003 | 0.052 | 0.050 | 0.919 | 0.269 |
| 5.6 | 1.55 ± 0.27 | 1.81 ± 0.57 | 0.59 ± 0.09 | 1.25 ± 0.20 | 1.08 ± 0.11 | 1.67 ± 0.24 | 1.72 ± 0.41 | 1.32 ± 0.19 | 1.90 ± 0.46 |
| 11.3 | 1.51 ± 0.08 | 1.89 ± 0.23 | 0.16 ± 0.04 * | 1.32 ± 0.30 | 1.63 ± 0.15 * | 2.13 ± 0.12 * | 2.07 ± 0.25 * | 1.00 ± 0.17 | 1.85 ± 0.19 * |
| 17.5 | 1.49 ± 0.27 | 2.58 ± 0.50 | 0.18 ± 0.03 * | 1.16 ± 0.21 | 1.43 ± 0.21 | 2.18 ± 0.22 * | 1.18 ± 0.31 | 0.56 ± 0.13 | 1.84 ± 0.16 * |
| 47.8 | 1.85 ± 0.20 * | 2.70 ± 0.39 * | 0.27 ± 0.04 * | 1.10 ± 0.23 | 1.27 ± 0.09 | 2.33 ± 0.49 * | 0.96 ± 0.16 | 0.66 ± 0.17 | 2.24 ± 0.22 * |
| 104.8 | 1.48 ± 0.33 | 1.45 ± 0.21 | 0.54 ± 0.07 | 1.19 ± 0.26 | 1.55 ± 0.42 | 1.94 ± 0.50 | 0.92 ± 0.22 | 1.65 ± 0.14 * | 2.11 ± 0.55 * |
| Probability of the diet effect | 0.241 | 0.046 | <0.001 | 0.947 | 0.331 | 0.093 | 0.035 | 0.008 | 0.221 |
| 5.6 | 0.85 ± 0.18 | 0.76 ± 0.23 | 0.82 ± 0.13 | 0.58 ± 0.14 | 0.94 ± 0.10 | 0.67 ± 0.11 | 1.78 ± 0.45 | 0.76 ± 0.16 | 0.80 ± 0.18 |
| 11.3 | 0.74 ± 0.11 | 0.41 ± 0.08 * | 0.81 ± 0.06 | 0.61 ± 0.15 | 1.17 ± 0.13 | 0.70 ± 0.06 | 1.46 ± 0.23 | 0.92 ± 0.23 | 0.75 ± 0.15 |
| 17.5 | 0.79 ± 0.10 | 0.49 ± 0.19 | 0.90 ± 0.10 | 1.27 ± 0.34 | 1.11 ± 0.24 | 0.81 ± 0.15 | 1.62 ± 0.47 | 0.81 ± 0.14 | 1.23 ± 0.31 |
| 47.8 | 1.35 ± 0.34 | 0.66 ± 0.19 | 0.84 ± 0.07 | 2.85 ± 1.24 * | 1.40 ± 0.13 | 1.22 ± 0.29 | 2.09 ± 0.69 | 2.11 ± 0.36 | 1.38 ± 0.29 |
| 104.8 | 1.40 ± 0.26 | 1.53 ± 0.37 | 0.74 ± 0.09 | 2.19 ± 0.37 | 0.93 ± 0.15 | 1.10 ± 0.15 | 3.69 ± 0.74 ** | 1.14 ± 0.11 | 1.53 ± 0.38 |
| Probability of the diet effect | 0.135 | 0.026 | 0.772 | 0.091 | 0.300 | 0.215 | 0.025 | 0.001 | 0.257 |
compared to control group; Values are mean ± SEM for six animals. * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001 compared to control group.
Figure 2Immunomodulation induced by increasing concentrations of FB on cytokine expression in both the jejunum and ileum—Heat map representation. R software (www.r-project.org) was used to establish the heat maps. This graphical representation reports individual values (here individual cytokines) contained in a matrix that are represented as gray intensity. The heat map on the left refers to all the data in both the jejunum and ileum, and at 10 and 20 days of age. For instance, the value of “10” for 11.3 mg/kg means that 10 significant upregulations of cytokines were found in both jejunum and ileum at days 10 & 20 following ingestion of 11.3 mg FB/kg. This latter heat map was then divided into three sub-heat maps (on the right) analyzing (i) the type of cytokines found to be upregulated, (ii) the effect of sampling time on the upregulation, and (iii) the fold increase of cytokine expression relative to the control group (low, 1.5–2.5 fold; mild, 2.5–4 fold).
Figure 3Overview of the biphasic response on cytokine expression in cecal tonsils (for diets containing 11.3, 17.5 and 47.8 mg FB/kg). Expression of cytokines related to inflammation, Treg response, and Th17 & Th1 responses at days 10 and 20. For each cytokine, the first three bars in white (□) correspond to 11.3, 17.5 and 47.8 mg FB/kg at day 10, and the following three bars in black (■) corresponds to 11.3, 17.5 and 47.8 mg FB/kg at day 20. The same order was used for each cytokine. The concentrations of 5.6 and 104.8 mg/kg had induced slight effects and were therefore omitted. Values are mean ± SEM for six animals. * p ≤ 0.05; ** p ≤ 0.01 compared to control group.
Figure 4Correlation in the ileum of free sphingosine content and gene expression, at day 10. Individual data (n = 36, 6 birds/diets) from the gene expression analysis for IFN-γ and SOCS1 correlated to the sphingosine analysis in the ileum of birds fed the experimental diets. r = Pearson correlation coefficient.
Diet formulation, nutrient specification and mycotoxin content.
| Item | Starter Diet | |||||
|---|---|---|---|---|---|---|
| Ingredient (% of diet) | ||||||
| Corn | 54.18 | |||||
| Soybean meal (48% CP) | 38.05 | |||||
| Soy oil | 3.52 | |||||
| Sodium chloride | 0.47 | |||||
| DL-Methionine | 0.25 | |||||
| Threonine | 0.07 | |||||
| 0.10 | ||||||
| Limestone | 1.68 | |||||
| Monocalcium phosphate | 1.33 | |||||
| Vitamin and mineral premix 1 | 0.35 | |||||
| Nutrient composition (calculated) | ||||||
| ME, kcal/kg | 3066 | |||||
| CP, % | 22.43 | |||||
| Ca, % | 1.01 | |||||
| Non-phytate phosphorus, % | 0.43 | |||||
| Met, % | 0.59 | |||||
| Thr, % | 0.92 | |||||
| Lys, % | 1.34 | |||||
| Analyzed composition | ||||||
| Fumonisin B1 | 0.26 | 3.9 | 7.1 | 11.0 | 31.7 | 66.9 |
| Fumonisin B2 | 0.09 | 1.4 | 3.4 | 5.1 | 12.4 | 27.5 |
| Fumonisin B3 | 0.02 | 0.3 | 0.8 | 1.4 | 3.7 | 10.4 |
| Deoxynivalenol | Range from 0.236 to 0.344 mg/kg | |||||
| Zearalenone | Range from 0.015 to 0.029 mg/kg | |||||
| Aflatoxin B1 | <LOD; LOD = 0.3 μg/kg | |||||
| Ochratoxin A | <LOD; LOD = 0.2 μg/kg | |||||
| T-2 toxin | <LOD; LOD = 25 μg/kg | |||||
1 Supplied the following per kilogram of diet: Iron, 71.6 mg; copper, 11.0 mg; manganese, 178.7 mg; zinc, 178.7 mg; iodine, 3.0 mg; selenium, 0.4 mg. vitamin A, 18,904 IU; vitamin D3, 9480 IU; vitamin E, 63.0 IU; vitamin K activity, 6.4 mg; thiamine, 3.2 mg; riboflavin, 9.4 mg; pantothenic acid, 34.7 mg; niacin, 126.0 mg; pyridoxine, 4.7 mg; folic acid, 1.6 mg; biotin, 0.5 mg; vitamin B12, 35.4 µg; choline, 956.9 mg. Bold and italic part, please explain.
Nucleotide sequence of primers for real-time PCR.
| Gene | Primer sequence | Amplicon | Ensembl access | References | |
|---|---|---|---|---|---|
| Size | Intron 1 | ||||
| GAPDH | F (300 nM) TCCTAGGATACACAGAGGACCA | 151 bp | 2 | ENSGALG00000014442 | Present study |
| RPL4 | F (300 nM) TTATGCCATCTGTTCTGCC | 235 bp | 2 | ENSGALG00000007711 | Present study |
| IL-1β | F (300 nM) GCATCAAGGGCTACAAGCTC | 131 bp | 1 | ENSGALG00000000534 | [ |
| IL-6 | F (300 nM) GAATGTTTTAGTTCGGGCACA | 130 bp | 0 | ENSGALG00000010915 | Present study |
| IL-8 | F (300 nM) GCGGCCCCCACTGCAAGAAT | 146 bp | 2 | ENSGALG00000011670 | Present study |
| IL-10 | F (300 nM) GCTGAGGGTGAAGTTTGAGG | 121 bp | 2 | ENSGALG00000000892 | Present study |
| TGFβ1 | F (300 nM) CGGGACGGATGAGAAGAAC | 258 bp | no data | [ | |
| SOCS1 | F (300 nM) CAAGCGGATTTCAGTAGCATC | 110 bp | no intron | ENSGALG00000007158 | Present study |
| IL-17 | F (300 nM) TATCAGCAAACGCTCACTGG | 110 bp | 1 | ENSGALG00000016678 | Present study |
| IL-21 | F (300 nM) GCTTTCAAAGACAATTGACCATC | 106 bp | 2 | ENSGALG00000011844 | Present study |
| IFN-γ | F (300 nM) AGCTGACGGTGGACCTATTATT | 259 bp | 2 | ENSGALG00000009903 | [ |
1 number of introns spanned in the design of primers, the brackets report the total size of introns (in bp). GAPDH, Glyceraldehyde 3-phosphate dehydrogenase; IFN-γ, Interferon-γ; IL, Interleukin; RPL4, Ribosomal protein L4; SOCS1, Suppressor of cytokine signaling 1; TGFβ1, Transforming growth factor β 1.